CMR Surgical

What CMR Surgical does

CMR Surgical is a UK-headquartered medical technology company that designs, develops, and manufactures the Versius Surgical Robotic System, a small, modular, and portable robotic-assisted surgery platform intended to make minimally invasive surgery more accessible to hospitals, ambulatory surgery centers, and surgical departments. Founded in 2014 in Cambridge and operating as a private limited company (Companies House No. 08863657), the firm reports a 501-1000 employee headcount and runs an enterprise field-sales go-to-market motion targeting healthcare providers across more than 30 countries. The Versius system is built on the company's patented V-Wrist instrument technology, which delivers 360-degree wrist rotation in a compact form factor that can be moved between operating rooms without dedicated infrastructure, paired with an integrated vLimeLite fluorescence visualization module and a digital ecosystem (Versius Connect, Versius Team, Versius Trainer) that supports software-led feature upgrades and procedural/operational analytics. As of March 2026 the company reports more than 45,000 patients treated globally, positioning Versius as the second most utilized robotic surgical platform worldwide behind Intuitive Surgical's da Vinci.

The company monetizes through a multi-stream model: one-time capital sales of Versius and Versius Plus systems (with hardware including bedside units, console, vision stack, electrosurgical and non-electrosurgical instruments); recurring revenue from fully-articulated consumable instruments and accessories, including the advanced Versius Energy Ultrasonic Dissector (not approved for sale in the United States); a multi-step training, implementation, and professional services programme delivered in partnership with surgical education bodies such as IRCAD and ORSI; recurring software and data value from the Versius Digital Ecosystem; and ongoing maintenance and service contracts through a global field-service organization. Pricing is quote-based and not publicly disclosed, with the company describing its model as a "partnership" approach with hospitals and ASCs. CMR Surgical has secured FDA de novo authorization (October 2024) and FDA 510(k) clearance for the next-generation Versius Plus (December 2025), formal U.S. market debut in March 2026, CE/UKCA pediatric approval (January 2026), and an active 510(k) submission for benign gynecology (April 2026). Recent strategic activity includes a $200M+ financing round in April 2025, exploration of a potential ~$4 billion sale in 2025, and a partnership with NVIDIA on the Open-H healthcare robotics dataset and Isaac GR00T-H vision-language-action model. The company is backed by SoftBank Vision Fund 2, Ally Bridge Group, Tencent, GE HealthCare's venture arm, Cambridge Innovation Capital, and others, with Trinity Capital providing growth debt in 2025.

Name

CMR Surgical

Legal name

CMR Surgical Limited

Website

https://cmrsurgical.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Short description

CMR Surgical develops the Versius and Versius Plus surgical robotic systems for minimally invasive surgery. Founded in 2014 in Cambridge, UK, the company has treated over 45,000 patients across 30+ countries, making Versius the second most utilized robotic surgical platform globally behind Intuitive Surgical.

Ownership category

akta.pro rank

Product category

Surgical Robotics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industry

Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity) (HLAHADAE)

Keywords

• Surgical robotic systems
• Robotic-assisted surgery
• Minimally invasive surgery
• Medical robotics
• Surgical instruments

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Capital Equipment Sales: One-time sale of Versius and Versius Plus surgical robotic systems to hospitals, ambulatory surgery centers, and surgical departments. Each system includes the bedside units, console, vision stack, and a suite of electrosurgical and non-electrosurgical instruments.
2. Recurring Consumables and Accessories: Recurring revenue from fully-articulated standard instruments, advanced instrumentation including the Ultrasonic Dissector, and other disposable/reposable accessories used per procedure. Industry-wide pattern of recurring instruments/accessories revenue is described as a core economic driver in surgical robotics.
3. Training, Implementation and Professional Services: Revenue and value from a seven-step, metrics-led training programme, residential courses at IRCAD/ORSI, hospital dry runs, preceptor support, and ongoing implementation services delivered by professional education teams.
4. Digital Ecosystem Software / Data Subscriptions: Software-led recurring value from the Versius ecosystem (Versius Connect, Versius Team), enabling feature and performance upgrades via software release without hardware replacement, and supporting clinical and operational performance monitoring.
5. Maintenance and Service Contracts: Ongoing technical support, field service (e.g., Germany Field Service Engineer roles), and system maintenance — typical of installed-base surgical robotics OEMs.

Pricing tiers

Go-to-market motion1 record

Core offering

CMR Surgical designs, develops, manufactures and commercialises surgical robotic systems for minimal access surgery. Its Versius platform combines modular robotic hardware, instruments, a visualisation system, and a digital ecosystem of applications that support surgical teams before, during and after procedures. The company's primary customers are hospitals and surgical centres performing laparoscopic and gynaecological procedures.

Product overview

CMR Surgical offers a single unified robotic-assisted surgical platform branded around the Versius Surgical Robotic System, with Versius Plus as the next-generation evolution that received FDA 510(k) clearance in December 2025 for cholecystectomy. The platform is architected as a core robotic system augmented by a portfolio of modules and digital ecosystem components: vLimeLite (integrated fluorescence visualization), Versius Energy (Ultrasonic Dissector instrumentation), Versius Connect (surgeon procedural logbook app), Versius Team (hospital operations dashboard app), the Versius Trainer (virtual reality simulator), and the Versius Digital Ecosystem that ties them together via software-led updates. Versius has been used in over 45,000 surgical cases worldwide, making it the second most utilized robotic surgical platform globally, and is supported by a comprehensive training program in partnership with surgical education bodies.

Differentiator

Problem solved

Functional benefit

Brands

• Versius: Small, modular and portable surgical robotic system designed to make minimal access surgery easier for hospitals and surgeons.
• Versius Plus
• vLimeLite

Products and services

• Versius Surgical Robotic System A modular robotic system for performing minimally invasive (laparoscopic) surgery. It uses individually cart-mounted robotic arms that can be moved between operating theatres and configured to suit the procedure, and is sold to hospitals and surgical centres.
• Versius Plus Next-generation surgical robotic system from CMR Surgical, building on the Versius architecture and adding native edge-AI compute (via NVIDIA IGX Thor) to enable real-time surgical AI features such as video analytics and decision support during procedures.
• vLimeLite A visualisation system integrated with the Versius platform that provides fluorescence imaging to help surgeons visualise anatomy and tissue perfusion during robotic-assisted procedures.
• Versius Connect A digital application that captures, analyses and shares surgical data from the Versius platform, supporting hospital reporting, performance monitoring and connectivity across the surgical team.
• Versius Team A digital application supporting coordination and communication across the surgical team using the Versius system, including scheduling, case planning and team workflows.
• Versius Trainer A virtual reality-based surgical training simulator that allows surgeons and theatre staff to train on Versius procedures outside the operating theatre, supporting proficiency development and credentialing.
• Versius Energy (Ultrasonic Dissector) An ultrasonic dissector instrument for the Versius system that delivers simultaneous dissection and coagulation of tissue during robotic-assisted minimally invasive surgery.
• Versius Digital Ecosystem The combined portfolio of digital applications (Versius Connect, Versius Team, Versius Trainer) that integrate with the Versius surgical robot to deliver data capture, analytics, team coordination and training around each procedure.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature7 records

Recent moves8 records

Expansion highlights8 records

Regional players

• SHURUI Robotics: China-based surgical robotics developer with CE-marked systems in Europe. Cited alongside Intuitive Surgical as one of the few companies with pediatric abdominal surgery approvals in Europe; serves as a regional/emerging competitor.

Emerging players

• THINK Surgical: Developer of the TMINI miniaturized robotic system for knee replacement and an active player in the orthopedic and emerging general-surgery robotics space. Comparable in size and commercialization stage to CMR.
• Moon Surgical: French-based developer of a compact, assistive surgical robotics platform (Maestro) targeting the laparoscopic soft-tissue surgery market. Comparable in philosophy (smaller, modular, OR-friendly) to CMR's Versius platform.
• Vicarious Surgical: Developer of a single-port surgical robotic system targeting abdominal procedures, with a digitally native architecture similar to CMR's Versius platform. Comparable in scale and clinical indication focus.
• Asensus Surgical: Developer of the Senhance laparoscopic surgical robotics system with machine-vision and instrument-tracking capabilities. Direct competitor in the soft-tissue minimally invasive surgery segment with a digital/AI emphasis similar to CMR's digital ecosystem.

Broad incumbents

• Smith+Nephew: Markets the CORI handheld robotics platform and is exploring surgical robotics expansion. A diversified medtech player with overlapping hospital customers and capital equipment sales motion comparable to CMR.
• Medtronic: Developer of the Hugo robotic-assisted surgery system, a modular platform competing directly with Versius. As a diversified medtech incumbent, Medtronic offers bundled OR solutions and competes head-to-head with CMR in general surgery indications.
• Stryker: Acquired MAKO Surgical and is expanding into soft-tissue surgical robotics through its established orthopedic and surgical equipment channels. Competes with CMR for hospital capital budgets and OR footprint.
• Intuitive Surgical: Developer of the da Vinci surgical robotic system, the dominant incumbent in robotic-assisted surgery with thousands of installed systems globally. Direct competitor to CMR's Versius platform; CMR is positioned as the second most-utilized surgical robotic platform behind Intuitive.
• Johnson & Johnson (Ethicon / Auris Health): Through its Ottava program and Auris Health acquisition (Monarch platform), J&J is developing a multi-specialty surgical robotics portfolio. A direct competitor with deep hospital relationships and capital to bundle robotics into existing surgical device contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/cmrsurgical
• YouTubeyoutube.com/channel/UCBOq2GA_dPH1HV3J0j0TLFg/videos
• LinkedInlinkedin.com/company/cmrsurgical
• Instagraminstagram.com/cmrsurgical
• Facebookfacebook.com/CMRSurgical

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds8 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CMR Surgical